Verified Nov 2026
Other
·

Canton, Michigan
·
Since 2006
MMS Holdings is a clinical research organization headquartered in Canton, Michigan, founded in 2006. With 500–1,000 employees and estimated revenue of $500M–$1B, the privately held company serves pharmaceutical, biotechnology, and medical device sectors across four continents. MMS provides regulatory writing, data science, drug safety, and quality compliance services, having supported over 50 drug approval submissions in the past five years.
MMS at a glance
Revenue
$500M-1B
Est. band
Employees
500-1,000
Founded
2006
Headquarters
Canton, Michigan
Industries
Automotive
Electric Vehicles
Medical
Overview
MMS Holdings is a clinical research organization headquartered in Canton, Michigan, founded in 2006. With 500–1,000 employees and estimated revenue of $500M–$1B, the privately held company serves pharmaceutical, biotechnology, and medical device sectors across four continents. MMS provides regulatory writing, data science, drug safety, and quality compliance services, having supported over 50 drug approval submissions in the past five years.
At a glance
Attribute | Detail |
|---|---|
Founded | 2006 |
Headquarters | Canton, Michigan |
Employees | 500-1,000 |
Revenue | $500M-1B (estimated) |
What MMS makes
MMS offers regulatory and medical writing, biometrics and data science, pharmacovigilance, quality assurance, and AI-powered clinical trial data analysis across multiple therapeutic areas including rare disease and psychedelic drug development.
Products and capabilities described on the company's own site include LED (source: mmsholdings.com).
Latest developments
2026-06-08 — MMS Holdings Expands West Coast Biotech Presence at BIO 2026 (mmsholdings.com)
2026-05-12 — MMS Names Ben Dudley President to Expand Global Leadership (mmsholdings.com)
2026-02-05 — MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions - MMS Holdings (mmsholdings.com)
2025-12-04 — Former FDA Leader Dr. Stephine Keeton Joins MMS as Senior Director of Biometrics (mmsholdings.com)
2025-10-02 — MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases - MMS Holdings (mmsholdings.com)
2025-08-19 — Advancing Oncology Trials: MMS and Friends of Cancer Research (mmsholdings.com)
Company details
The company operates across four continents with over 800 employees and was recognized as Best Data-Focused Pharmaceutical Clinical Research Organisation in the USA at the GHP Global Excellence Awards 2023. MMS was founded in 2006, has an estimated 500-1,000 employees, and is headquartered in Canton, Michigan.
Frequently asked questions
What does MMS do?
MMS Holdings is a clinical research organization headquartered in Canton, Michigan, founded in 2006. With 500–1,000 employees and estimated revenue of $500M–$1B, the privately held company serves pharmaceutical, biotechnology, and medical device sectors across four continents. MMS provides regulatory writing, data science, drug safety, and quality compliance services, having supported over 50 drug approval submissions in the past five years.
Where is MMS headquartered?
MMS is headquartered in Canton, Michigan (6880 Commerce Boulevard, Canton, Michigan, 48187).
When was MMS founded?
MMS was founded in 2006.
How big is MMS?
MMS has an estimated 500-1,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
